U.S. markets closed

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
8.96+0.21 (+2.40%)
Al cierre: 04:00PM EDT
8.93 -0.03 (-0.33%)
Fuera de horario: 07:20PM EDT

Nómina de miembros de la gerencia

Persona o entidadTransacción más recienteFechaAcciones adquiridas a partir de la fecha de transacción

BERGER MARK STANLEY
Officer

Conversion of Exercise of derivative security

04 mar 2019

22,500

DAVE KAUSHIK J PH.D.
Chief Executive Officer

Purchase

13 abr 2016

88,500

LUDWIG DALE L
Officer

Purchase

18 nov 2018

10,000

MEMORIAL SLOAN KETTERING CANCER CENTER
Beneficial Owner of more than 10% of a Class of Security

Sale

30 ago 2016

4,709,560

O LOUGHLIN STEVE
Officer

Purchase

09 dic 2018

35,500

RAY NITYA G.
Officer

Purchase

01 ago 2017

10,000

SETH SANDESH
Chief Executive Officer

Stock Award(Grant)

16 ago 2022

305,381

SHETTY AJIT S
Director

Purchase

27 feb 2018

22,730

STEINHART RICHARD I
Director

Purchase

13 abr 2016

2,500

TRAVERSA SERGIO
Director

Purchase

14 abr 2016

3,000

*La lista miembros de la gerencia se deriva únicamente de los últimos 24 meses de las presentaciones SEC de las Planillas 3 y 4.